SANGAMO THERAPEUTICS
Sangamo Therapeutics is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.
SANGAMO THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Pharmaceutical Therapeutics
Founded:
1995-01-01
Address:
Richmond, California, United States
Country:
United States
Website Url:
http://www.sangamo.com
Total Employee:
251+
Status:
Active
Contact:
5102368951
Email Addresses:
[email protected]
Total Funding:
522.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving Wordpress Plugins Mobile Non Scaleable Content Nginx Sitelinks Search Box
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Agenus
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
Altor BioScience
Altor BioScience researches and develops immunotherapeutic agents for the treatment of cancer, viral infections and autoimmune diseases.
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2018-07-23 | TxCell | TxCell acquired by Sangamo Therapeutics | 72 M EUR |
2013-08-26 | Ceregene | Ceregene acquired by Sangamo Therapeutics | N/A |
Investors List
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine investment in Grant - Sangamo Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - Sangamo Therapeutics
Key Employee Changes
Date | New article |
---|---|
2020-04-17 | Sangamo Appoints D. Mark McClung as Executive Vice President and Chief Business Officer |
Official Site Inspections
http://www.sangamo.com Semrush global rank: 2.16 M Semrush visits lastest month: 9.21 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago